Abstract
Mood disorders, especially depression, are a major cause of human disability. The loss of pleasure (anhedonia) is a common, severely debilitating symptom of clinical depression. Experimental animal models are widely used to better understand depression pathogenesis and to develop novel antidepressant therapies. In rodents, various experimental models of anhedonia have already been developed and extensively validated. Complementing rodent studies, the zebrafish (Danio rerio) is emerging as a powerful model organism to assess pathobiological mechanisms of affective disorders, including depression. Here, we critically discuss the potential of zebrafish for modeling anhedonia and studying its molecular mechanisms and translational implications.
Author supplied keywords
Cite
CITATION STYLE
De Abreu, M. S., Costa, F., Giacomini, A. C. V. V., Demin, K. A., Zabegalov, K. N., Maslov, G. O., … Kalueff, A. V. (2022, April 1). Towards Modeling Anhedonia and Its Treatment in Zebrafish. International Journal of Neuropsychopharmacology. Oxford University Press. https://doi.org/10.1093/ijnp/pyab092
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.